SLC7A11 and cancer: Mechanistically, system Xc-, a cystine/glutamate antiporter system, composed of a light-chain subunit SLC7A11 (xCT) and a heavy-chain submit SLC3A2 (CD98), is a promising target for inhibiting ferroptosis in cancer cells 6.